The new law should limit the overall tort liability confronted by all types of companies and individuals who find themselves facing a lawsuit in Florida. This update focuses on the changes for statutes of limitation, comparative negligence and the admissibility of evidence of medical charges at trial. Florida courts will undoubtedly see many challenges to the new law over the next few years.
Read the full article on the Faegre Drinker website.
The material contained in this communication is informational, general in nature and does not constitute legal advice. The material contained in this communication should not be relied upon or used without consulting a lawyer to consider your specific circumstances. This communication was published on the date specified and may not include any changes in the topics, laws, rules or regulations covered. Receipt of this communication does not establish an attorney-client relationship. In some jurisdictions, this communication may be considered attorney advertising.
About the Author: Traci T. McKee
As a product liability litigator, Traci McKee defends medical devices and pharmaceutical products that save lives and consumer products that enhance lives. She represents product manufacturers in complex, high stakes litigation such as mass torts and class actions, as well as single-plaintiff claims. With more than a decade of litigation practice, Traci has substantial experience in all phases of litigation from discovery through trial, having served as first chair and second chair in multiple jury trials. She understands the strategies and goals of the clients she represents and develops tailored litigation strategies focused on each client’s business goals.
About the Author: Andrew G. Jackson
Andrew Jackson brings next-level energy, all-in dedication to clients and a team-first mentality to Faegre Drinker's award winning and nationally ranked product liability and mass tort litigation practice. Specializing in drug and device defense, Andrew is regularly tasked with taking on large, complicated projects and delivering uncomplicated, trial-ready solutions.
